C71T
CANCELLED SECTION 71
02/06/2026
Back to search
Official data from USPTO
BICYCLE TARGETED IMMUNE ACTIVATOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BICYCLE TARGETED IMMUNE ACTIVATOR
ST13
US500000079237928Class
5, 42
Filing
79237928
Registration
5809118
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/03/2026
Trademark type
Word
Nice classes
5, 42
Filing date
03/09/2018
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CORDOVA, RAUL
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bicycletx Limited
Bicycle Therapeutics Limited
Representatives
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for use in oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disorders; pharmaceutical preparations for use as diagnosticsdiagnostic preparations for medical use and for use as clinical imaging agents
Class 42
Scientific and technological services and research and design relating theretoscientific researchnew product design servicesnew study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; informationconsultancy and advisory services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
38 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/26/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/26/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/26/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/23/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/01/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/24/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/17/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2019
FIMP
FINAL DISPOSITION PROCESSED
11/18/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/21/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/21/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/21/2019
RFNT
REFUSAL PROCESSED BY IB
09/08/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/23/2018
RFRR
REFUSAL PROCESSED BY MPU
08/23/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/15/2018
CNRT
NON-FINAL ACTION WRITTEN
08/14/2018
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2018
DOCK
ASSIGNED TO EXAMINER
08/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/02/2018
Continuous trademark protection
Get notified about every new filing that threatens BICYCLE TARGETED IMMUNE ACTIVATOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.